<DOC>
	<DOCNO>NCT00419393</DOCNO>
	<brief_summary>To provide continued treatment Keppra XR ( Levetiracetam XR ) ass long term safety Keppra XR subject partial onset seizure .</brief_summary>
	<brief_title>Long Term Follow-up Study With Keppra XR ( Levetiracetam XR ) Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subjects randomize study N01280 [ NCT00419094 ] , complete 2 week titration period Subjects meet inclusion/exclusion criterion N01280 [ NCT00419094 ] Subjects discontinue prior end titration period</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Keppra XR</keyword>
	<keyword>Levetiracetam XR</keyword>
	<keyword>long term</keyword>
	<keyword>partial seizure</keyword>
</DOC>